- Home
- ZLAB vs KBH Comparison
ZLAB vs KBH Comparison
Compare ZLAB & KBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- KBH
- Stock Information
- Founded
- ZLAB 2013
- KBH 1957
- Country
- ZLAB China
- KBH United States
- Employees
- ZLAB N/A
- KBH N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- KBH Homebuilding
- Sector
- ZLAB Health Care
- KBH Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- KBH Nasdaq
- Market Cap
- ZLAB 3.6B
- KBH 3.8B
- IPO Year
- ZLAB 2017
- KBH 1987
- Fundamental
- Price
- ZLAB $40.63
- KBH $53.01
- Analyst Decision
- ZLAB Buy
- KBH Buy
- Analyst Count
- ZLAB 4
- KBH 12
- Target Price
- ZLAB $47.37
- KBH $71.71
- AVG Volume (30 Days)
- ZLAB 1.0M
- KBH 1.0M
- Earning Date
- ZLAB 08-05-2025
- KBH 06-23-2025
- Dividend Yield
- ZLAB N/A
- KBH 1.89%
- EPS Growth
- ZLAB N/A
- KBH 11.73
- EPS
- ZLAB N/A
- KBH 8.22
- Revenue
- ZLAB $418,326,000.00
- KBH $6,854,097,000.00
- Revenue This Year
- ZLAB $44.07
- KBH N/A
- Revenue Next Year
- ZLAB $49.13
- KBH N/A
- P/E Ratio
- ZLAB N/A
- KBH $6.45
- Revenue Growth
- ZLAB 43.72
- KBH 5.54
- 52 Week Low
- ZLAB $16.01
- KBH $48.90
- 52 Week High
- ZLAB $44.34
- KBH $89.70
- Technical
- Relative Strength Index (RSI)
- ZLAB 67.47
- KBH 49.53
- Support Level
- ZLAB $37.02
- KBH $52.04
- Resistance Level
- ZLAB $44.34
- KBH $55.95
- Average True Range (ATR)
- ZLAB 1.36
- KBH 1.46
- MACD
- ZLAB 0.87
- KBH 0.19
- Stochastic Oscillator
- ZLAB 75.39
- KBH 51.00
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About KBH KB Home
KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.